These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34204379)

  • 21. Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries.
    Marzo RR; Ahmad A; Islam MS; Essar MY; Heidler P; King I; Thiyagarajan A; Jermsittiparsert K; Songwathana K; Younus DA; El-Abasiri RA; Bicer BK; Pham NT; Respati T; Fitriyana S; Faller EM; Baldonado AM; Billah MA; Aung Y; Hassan SM; Asad MM; El-Fass KA; Bhattacharya S; Shrestha S; Hamza NAE; Friedmann P; Head M; Lin Y; Yi S
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010103. PubMed ID: 35089917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between risk perception and influenza vaccine hesitancy for children among reproductive women in China during the COVID-19 pandemic: a national online survey.
    Du M; Tao L; Liu J
    BMC Public Health; 2022 Feb; 22(1):385. PubMed ID: 35197035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
    Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
    Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sociodemographic predictors of and main reasons for COVID-19 vaccine hesitancy in eastern Oslo: a cross-sectional study.
    Steinmetz L
    BMC Public Health; 2022 Oct; 22(1):1878. PubMed ID: 36207702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing COVID-19 Vaccine Hesitancy From a Decisional Conflict Model: A Cross-Sectional Study.
    Hiroyama N; Okubo N; Takahashi N; Misumi J
    Inquiry; 2023; 60():469580231162524. PubMed ID: 36949732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The vaccine hesitancy continuum among hesitant adopters of the COVID-19 vaccine.
    Moore R; Purvis RS; Willis DE; Worley KC; Hervey D; Reece S; Yeates A; McElfish PA
    Clin Transl Sci; 2022 Dec; 15(12):2844-2857. PubMed ID: 36330587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the relationship between moral values and vaccine hesitancy in Great Britain during the COVID-19 pandemic: A cross-sectional survey.
    Schmidtke KA; Kudrna L; Noufaily A; Stallard N; Skrybant M; Russell S; Clarke A
    Soc Sci Med; 2022 Sep; 308():115218. PubMed ID: 35870299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parental vaccine hesitancy and concerns regarding the COVID-19 virus.
    Salazar TL; Pollard DL; Pina-Thomas DM; Benton MJ
    J Pediatr Nurs; 2022; 65():10-15. PubMed ID: 35367855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Socio-Demographic Factors Associated With COVID-19 Vaccine Hesitancy Among Middle-Aged Adults During the Quebec's Vaccination Campaign.
    Jantzen R; Maltais M; Broët P
    Front Public Health; 2022; 10():756037. PubMed ID: 35372193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study.
    Huang Y; Zhang L; Fu J; Wu Y; Wang H; Xiao W; Xin Y; Dai Z; Si M; Chen X; Jia M; Leng Z; Cui D; Su X
    JMIR Public Health Surveill; 2023 Jul; 9():e42958. PubMed ID: 37247615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public Willingness and Determinants of COVID-19 Vaccination at the Initial Stage of Mass Vaccination in China.
    Zhao YM; Liu L; Sun J; Yan W; Yuan K; Zheng YB; Lu ZA; Liu L; Ni SY; Su SZ; Zhu XM; Zeng N; Gong YM; Wu P; Ran MS; Leng Y; Shi J; Shi L; Lu L; Bao YP
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
    Luk TT; Lui JHT; Wang MP
    J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 vaccine acceptance and hesitancy in N'Djamena, Chad: A cross-sectional study of patients, community members, and healthcare workers.
    Rice DR; Balamo A; Thierry AR; Gueral A; Fidele D; Mateen FJ; Sakadi F
    PLOS Glob Public Health; 2022; 2(6):e0000608. PubMed ID: 36962369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing parents' hesitancy to vaccinate their children aged 5-11 years old against COVID-19: results from a cross-sectional study in Malaysia.
    Marzo RR; Chakraborty R; Soh SY; Thew HZ; Chong C; Siau CS; Abdul Wahab KB; Binti Ariffin IA; Chauhan S; Brackstone K; Padhi BK; Heidler P
    Front Public Health; 2023; 11():1091015. PubMed ID: 37261237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries.
    Leigh JP; Moss SJ; White TM; Picchio CA; Rabin KH; Ratzan SC; Wyka K; El-Mohandes A; Lazarus JV
    Vaccine; 2022 Jul; 40(31):4081-4089. PubMed ID: 35654620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global state of education-related inequality in COVID-19 vaccine coverage, structural barriers, vaccine hesitancy, and vaccine refusal: findings from the Global COVID-19 Trends and Impact Survey.
    Bergen N; Kirkby K; Fuertes CV; Schlotheuber A; Menning L; Mac Feely S; O'Brien K; Hosseinpoor AR
    Lancet Glob Health; 2023 Feb; 11(2):e207-e217. PubMed ID: 36565702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How prevalent is COVID-19 vaccine hesitancy in low-income and middle-income countries and what are the key drivers of hesitancy? Results from 53 countries.
    Dayton Eberwein J; Edochie IN; Newhouse D; Cojocaru A; Bopahbe GD; Kakietek JJ; Kim YS; Montes J
    BMJ Open; 2023 Nov; 13(11):e069152. PubMed ID: 37931970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 vaccine hesitancy and attitudes in Pakistan: a cross-sectional phone survey of major urban cities.
    Khan AA; Abdullah M; Aliani R; Mohiuddin AF; Sultan F
    BMC Public Health; 2023 Jun; 23(1):1112. PubMed ID: 37296386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study.
    Woolf K; McManus IC; Martin CA; Nellums LB; Guyatt AL; Melbourne C; Bryant L; Gogoi M; Wobi F; Al-Oraibi A; Hassan O; Gupta A; John C; Tobin MD; Carr S; Simpson S; Gregary B; Aujayeb A; Zingwe S; Reza R; Gray LJ; Khunti K; Pareek M;
    Lancet Reg Health Eur; 2021 Oct; 9():100180. PubMed ID: 34308406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 Vaccine-Related Attitudes and Beliefs in Canada: National Cross-sectional Survey and Cluster Analysis.
    Benham JL; Atabati O; Oxoby RJ; Mourali M; Shaffer B; Sheikh H; Boucher JC; Constantinescu C; Parsons Leigh J; Ivers NM; Ratzan SC; Fullerton MM; Tang T; Manns BJ; Marshall DA; Hu J; Lang R
    JMIR Public Health Surveill; 2021 Dec; 7(12):e30424. PubMed ID: 34779784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.